UK flag Brexit: What We Are (And Aren't) Doing Get the Fool's analysis on what the UK leaving the EU means for investors

A medical technology company in orthopaedics products. Its products include implants, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation.


Updates from The Motley Fool

Latest updates on Stryker from Fool.com.


Stock Performance

SYK vs. S&P 500 | 2 Year Performance
View Interactive SYK Charts
Sponsored by

Key Data Points

Primary metrics and data points about Stryker.
Current Price: $116.59
Prev Close: $118.38
Open: $114.87
Bid: $113.16
Ask: $120.00
Day's Range: $114.41 - $117.92
52wk Range: $86.68 - $117.92
Volume: 4,519,256
Avg Vol 1,214,538
Market Cap: $43.78B
P/E (ttm): 64.69
EPS (ttm): $1.83
Div & Yield: $1.52 (1.3%)

Company Rating

What our community thinks about Stryker.
CAPS Rating 5 out of 5
 
1397 Outperform
30 Underperform
CAPS All Stars
 
431 Outperform
6 Underperform

How do you think Stryker will perform against the market?



You pick for Stryker is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Kevin A. Lobo, CEO

90% Approve

Based on 391 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Stryker.

A medical technology company in orthopaedics products. Its products include implants, trauma, craniomaxillofacial and spinal surgeries; biologics; surgical, neurologic, ear, nose & throat and interventional pain equipment; endoscopic, surgical navigation.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Healthcare IT